A novelly designed protein antagonist confers potent neutralization against SARS-CoV-2 variants of concern.
Lv P, Hu B, Hua R, Zhang J, Zhang H, Liu Z, Xu L, He Z, Li X, Guo M, Pan K, Zhang Z, Zeng Q, Wu Z, Sun L, Guo M, Zhou L, Xu X, Yu B, Xu J, Yuan S, Guo M, Cai K, Xia Y, Li Y.
Lv P, et al. Among authors: li y, li x.
J Infect. 2022 Sep;85(3):e72-e76. doi: 10.1016/j.jinf.2022.06.001. Epub 2022 Jun 3.
J Infect. 2022.
PMID: 35667483
Free PMC article.
No abstract available.